The CD45 antigen is a haemopoietic cell specific tyrosine phosphatase essential for antigen receptor mediated signalling in lymphocytes. Expression of different patterns of alternatively spliced CD45 isoforms is associated with distinct functions.
We recently identified a polymorphism in exon 6 (A138G) of the gene encoding CD45 (PTPRC) that results in altered CD45 splicing. The 138G allele is present at a high frequency among Japanese (23.7%), with 5.1% individuals homozygous for the G allele. In this study we show that the A138G polymorphism is the cause of altered CD45 isoform expression, promoting splicing towards low molecular weight CD45 isoforms. We further report that the frequency of A138G heterozygotes is significantly reduced in number in cohorts of patients with autoimmune Graves' disease or hepatitis B infection, while G138G homozygotes are absent from a cohort of Hashimoto's thyroiditis patients. We also show that 138G individuals exhibit altered cytokine production in vitro and an increased proportion of memory T cells.
These data suggest that the 138G variant allele strongly influences these diseases by modulation of immune mechanisms and may have achieved its high frequency as a result of a natural selection probably related to pathogen resistance.
INTRODUCTION
The CD45 (leucocyte common) antigen is a haemopoietic cell specific tyrosine phosphatase essential for antigen receptor mediated signalling in lymphocytes (1, 2) .
Mice and humans lacking CD45 expression are severely immunodeficient. Expression of different patterns of alternatively spliced CD45 isoforms in lymphocytes is associated with distinct functions, but the role of each isoform is unknown (3) . In humans, naïve T cells express high molecular weight isoforms containing the fourth or A exon ("CD45RA" cells), but following activation the low molecular weight CD45R0 isoform is expressed ("CD45R0" cells). Point mutations in the A exon of CD45 have been suggested to be associated with multiple sclerosis, autoimmune hepatitis, systemic sclerosis and HIV infection in humans (4) (5) (6) (7) (8) . These polymorphisms (C77G and C59A) prevent the splicing of exon 4, resulting in the presence of an increased proportion of lymphocytes expressing CD45RA-containing isoforms (9, 10) . Although the C77G variant appears to be associated with certain diseases the results from these studies are difficult to interpret because of the low frequency of the variant allele (11) (12) (13) (14) .
We recently identified another polymorphism (A138G) in exon 6 of CD45. The polymorphism results in an amino acid substitution, of Thr-47 to Ala in exon 6 and interferes with CD45 alternative splicing (15) . In contrast to the C77G variant, peripheral blood T cells from individuals carrying the 138G allele show an increase in the proportion of CD45R0+ cells and a decrease in naïve phenotype T cells expressing CD45RA. The 138G allele is present at a high frequency among Koreans (7.3%) and Japanese (23.7%). In Caucasoids the allele appears to be relatively rare (1.7% in Italians (14) and 0.4% in the UK (15) (15) . Here we investigate whether the 138G variant is associated with thyroid autoimmune disorders (Hashimoto's thyroiditis and Graves disease) and viral infections (hepatitis B and hepatitis C). We studied the phenotype and cytokine production of lymphocytes from individuals with the 138G variant and using a minigene containing the A138G mutation, we examined the effect of the variant on CD45 splicing.
Results
A minigene containing the A138G mutation shows increased splicing of exon 6 We have previously shown by both RT-PCR and flow cytometric analysis that 138G carriers have increased CD45R0 expression in PBMC (15) . We suggested that the mechanism for the altered isoform expression is the A138G substitution in exon 6, since it has been reported previously that changes in this region of exon 6 affect isoform expression, promoting skipping of exon 6 (16). Indeed Tsai et al (16) have shown that mutations of nucleotides 134 to 144 at the most 3' end of exon 6 (LS37 minigene construct) resulted in CD45 mRNA that did not include the exon 6 sequence regardless of whether it was synthesized in B cells or in thymocytes. In contrast the control pSV-mini-LCA30 construct could be alternatively spliced and in EL-4 produced both kinds of transcripts, one including the exon 6 sequence and one without (16) (Fig. 1A andB) . In order to examine the role of 138G variant on CD45 splicing we introduced the 138G mutation into pSV-mini-LCA30 generating the LS138G construct. We then compared the (Fig 1A and B) .
Consistent with previous studies, the pSV-mini-LCA30 can produce both ex2-6-8 and ex2-8 transcripts with a ratio of 12.1, while with LS37 the skipping of exon 6 is significantly increased, almost all the product is ex 2-8, and the ratio is 0.6 ( Fig 1C) .
Analysis of transcripts derived from the LS138G construct shows an increase in exclusion of exon 6, resulting in more exon 2-8 product and a decrease in the ratio to 6.4.
Taken together these data provide direct evidence that the 138G mutation is the cause of the altered CD45 phenotype in 138G carriers.
Frequency of the 138G variant in autoimmune and infectious diseases
We studied the frequency of the 138G variant in cohorts of Japanese patients with thyroid autoimmune conditions. In Hashimoto's thyroiditis, cellular and humoral responses to thyroid antigens lead to destruction of the organ and hypothyroidism, while Graves' disease (GD) is characterised by hyperthyroidism, caused by stimulatory thyrotropin receptor antibodies. We analysed 126 Hashimoto patients and found 50 A138G heterozygotes (allele frequency, 19.8%), comparable to the frequency in the control population (23.7%) ( Table 1 
Phenotypic analysis of PBMC
Since altered immune phenotypes and function are significant features of both animal model and human autoimmune diseases, we next sought evidence for this in individuals carrying the 138G allele. CD45RA and CD45R0 expression defines subsets of CD4 and CD8 cells that have been termed naïve and memory cells (17) . We have already reported that the proportions of these subsets are altered in individuals carrying the 138G variant allele (15) . Here we examined other markers that either distinguished naïve and memory cells or the proportions of memory subsets. Our aim was to determine whether only 7 CD45 isoform expression was affected or whether the CD45RA and CD45R0 cells in 138G individuals also exhibited characteristic 'naïve' and 'memory' phenotypes.
Peripheral blood mononuclear cells (PBMC's) from healthy G138G homozygotes, A138G heterozygotes and A138A control homozygotes were analysed by flow cytometry. All the G138G variant samples showed the previously described increased proportion of CD45R0+ T cells (15); among CD8 cells the mean was 49.4+/-8.9%, as compared to 18.9+/-9.3% in controls (p=0.03) (Fig. 2a) , and in the CD4 subset the mean was 48.4+/-9.3 % versus 32.8+/-9.3% in A138A controls. A138G heterozygotes show an intermediate CD45R0+ phenotype for CD8 and CD4 cells (data not shown). Furthermore G138G individuals exhibit decreased expression of CD27, CD28, CD62L and CCR7 and increased expression of CD11a and CD95 in CD8 cells (Fig. 2b) . Less exaggerated changes in expression of these markers were detected in the CD4 cells (Fig. 2c) . These changes suggest that the most prominent effect in 138G carrying individuals is an increase in the proportion of memory T cells.
Cytokine production by PBMC
We next analysed cytokine production in PBMC from 138G carrying individuals.
Intracytoplasmic flow cytometric analysis after stimulation by PMA and ionomycin showed that G138G cells have a significantly higher frequency of intracytoplasmic IFNgamma positive CD4 and CD8 cells (30.7% versus 18.9% in CD4 and 35.3% versus 9.7% in CD8 cells, Table 2 ). Heterozygotes showed an intermediate frequency of cytokine-positive cells in both T cell subsets (Table 2 and Fig. 3 ). Under the conditions of these assays using cryopreserved PBMC, intracytoplasmic staining for cytokines other 
Discussion
In this study we show a protective effect of the 138G variant in cohorts of patients with autoimmune Graves' disease and hepatitis B infection. We provide direct evidence that the A138G mutation is a cause of altered CD45 isoform expression and preliminary evidence that 138G individuals exhibit increased numbers of memory/activated lymphocytes and increased IFN-gamma production.
There are several possible explanations for the effect of the 138G variant. An important factor in the pathogenesis of autoimmune diseases is a change in the balance between Th1 cytokines, which promote cell mediated immunity, and Th2 cytokines, which promote humoral immunity. In Graves' disease there is a shift toward Th2 cytokine responses (18, 19) , while Hashimoto's patients show Th1 activation (20) . It is possible that increased IFN-gamma production in 138G carriers would counteract the Th2 cytokine deviation in Graves' disease. Furthermore it has been suggested that activated (IFN-gamma-producing) CD8 cells may reduce the pathogenic Th2 dominance in Graves' disease (19, 21) . In contrast increased IFN-gamma production in the 138G variant might not affect the disease course and already polarised Th1 cytokine balance in Hashimoto's thyroiditis. However, the lack of G138G homozygotes in Hashimoto's thyroiditis suggests the possibility of a specific recessive effect in homozygotes, which needs further investigation. Further analysis of immune function in diseased individuals may provide insights into the role of CD45 variant alleles in protection against disease or disease pathogenesis.
The contribution of CD8 cells to the control of hepatitis B virus infection is well documented (22) . In addition to clearance of infected cells by cytolytic CD8 cells, the anti-viral effect of IFN-gamma produced by these cells has been shown to be an important protective mechanism (23) . It is very likely that the increased proportions of activated T cells and IFN-gamma production in A138G neonates would limit amplification of the virus. Furthermore it has been suggested that neonates have Th2 biased immune responses (24, 25) . It is therefore possible, that the prevalence of Th1 cytokines in A138G infants would be beneficial at this early stage of life in controlling hepatitis B infection, while it would not have such a significant impact later in life. This might be the case for the hepatitis C cohort we have studied. Whatever the mechanism, comparisons of immune responses of individuals carrying or lacking the 138G allele may provide insights into the molecular mechanisms underlying the interactions between hepatitis B and hepatitis C viruses and IFN-gamma. Clearly, further independent cohort studies, family based approaches and immune functional studies in normal individuals and patients, need to be performed to confirm our preliminary functional data and elucidate the role of this polymorphism in disease incidence and progression.
The expression of CD45 is essential for normal development and function of lymphocytes. Both mice and humans lacking CD45 expression are severely immunodeficient (26) (27) (28) (29) . However, notwithstanding the clear evidence that CD45 expression is essential for normal lymphocyte function and that N-terminal alternative splicing is conserved in fish, birds and mammals (30, 31) , there is no clear understanding of the role of CD45 isoforms in lymphocyte function. In mice a point mutation in the cytoplasmic domain has been associated with a lupus-like autoimmune disease (32) and the authors postulated that this was due to an effect on dimerisation of CD45 molecules.
Others have shown that a large extracellular domain is required for TcR signalling in transfected cell lines (33) . On the other hand evidence from transgenic mice expressing single CD45 isoforms suggests that different isoforms reconstitute immune function equally well if they are equally well expressed (34) . Here we show that a relatively subtle alteration in alternative splicing is associated with altered disease susceptibility and increased IFN-gamma production. The mechanism of these effects is not known, but CD45 has been reported to affect cytokine signalling pathways (35) . We speculate therefore that specific combinations, rather than individual CD45 isoforms may have the most profound effect on signalling. In 138G individuals excess expression of low molecular weight CD45 isoforms may lead to altered signalling and increased IFNgamma production. This in turn may affect disease susceptibility.
There have been previous reports of altered CD45 isoform expression in disease (36-38) but we describe here what we believe is evidence that genetic variants affecting CD45 isoform expression are associated with autommunity and viral infection. Although one possibilty is that the effect of the 138G allele is neutral, the most likely explanation for the high frequency of this variant is natural selection. In contrast to this allele, most neutral polymorphic variants are at a lower frequency and are changes in third base pair positions or in introns. Given the functional effect and high frequency of the 138G variant not only in Japanese but also in China (unpublished data) and Korea (15) antigen. In all samples HCV RNA was detected, except for four patients who had cleared the virus (two of these were A138G heterozygous and one G138G homozygous). In the hepatitis C group of patients, 13% were carriers, 58% had chronic hepatitis, 16% liver cirhosis, 10% hepatocellular carcinoma and 3% had cleared the virus. Control genomic DNA samples from 176 Japanese, collected from Osaka City University Medical School, have been described previously (15) . All of the control and patient groups studied are of similar ethnic origin and live in the area surrounding the Osaka University Hospital.
Materials and Methods

Materials
Approval was obtained from the ethical committee of the City University Graduate School of Medicine Osaka and the patients gave consent for the study.
Amplification refractory mutation system (ARMS) PCR
To detect carriers of the exon 6 A138G mutations, we used the amplification refractory mutation system (ARMS) PCR, with two separate reaction mixes, containing one forward primer and one of the two reverse primers as previously described (15) . The presence of the 138G variant allele in all of the samples was confirmed by sequencing.
Flow cytometric analysis
Surface phenotypic analysis and intracytoplasmic staining for interferon gamma (IFNgamma) were performed on cryopreserved PBMC (shipped from Japan to the UK) from 6 healthy A138A controls and 4 healthy G138G homozygous carriers. Cells from 4 A138G heterozygotes were also analysed (data not shown). The ages of all subjects in this study were between 27 and 58 years. 
Statistical analysis
Chi-Square test, using Yates continuity correction to allow for small numbers was used to analyse the disease association of the 138G variant allele. For comparison of phenotypic analyses between cell subsets in A138G and control individuals, Student's t test assuming equal variance. In addition we have also reanalysed the data using the non parametric Mann-Witney test, because the data may not be normally distrubuted.
Minigene constructs
The minigene pSV-mini-LCA30 has been described previously (16) (kindly provided by H Saito, Dana Faber Cancer Institute, Boston, USA) and contains exons 2, 6 and 8 under the control of the SV40 early promoter (Fig. 1A) . It has been demonstrated that the pSVmini-LCA30 can be alternatively spliced to produce two kinds of transcripts, one including the exon 6 sequence and one without (Fig. 1B) . The LS37 minigene was also used (Fig. 1A) and contains mutation of nucleotides 134 to 144 at the most 3' end of exon 6, which have been shown to result in CD45 mRNA that did not include the exon 6 sequence (16).
To study the effect of the 138G mutation on splicing, the 138G substitution was introduced into the pSV-mini-LCA30 construct according to the QuickChange SiteDirected Mutagenesis Kit (Stratagene) generating construct LS138G. Clones containing the 138G mutation were identified by sequencing. Exponentially growing Cos-7 cells (5x10 6 cells) were mixed with 1µg of the linearised (PvuI digested) respective construct in PBS, then subjected to electroporation (Bio-Rad Gene Pulser II, Bio-Rad, Hemel
Hempsted, UK) at 25µF and 280V. After 48 hours cells were harvested and resuspended in TRI-reagent (Sigma) for RNA extraction and RT-PCR analysis as described below.
Six independent transfections were performed and analysed for each minigene.
RT-PCR analysis
Total RNA was extracted from the transfected cells and cDNA synthesis performed 
